Furthermore, CTRP9 inhibited inflammation by reducing the production of proinflammatory cytokines and downregulated the expression of tight junction protein, thereby preventing blood-retinal barrier degradation and vascular leakage in diabetic retinopathy mice (Li et al., 2019). The gene discussed is C1QTNF9; the disease is diabetic retinopathy.